Medicinal Products

Palexia 20 mg/ml oralna otopina

Name Palexia 20 mg/ml oralna otopina
Marketing Authorisation Number HR-H-173293107
Active Substance tapentadolklorid
Composition 1 ml oralne otopine sadrži 20 mg tapentadola (u obliku tapentadolklorida)
Pharmaceutical Form oralna otopina
Manufacturer Grünenthal GmbH, Aachen, Njemačka
Marketing Authorisation Holder Grünenthal GmbH, Zieglerstraße 6, Aachen, Njemačka
Marketing Authorisation Date 27.07.2015
MA Period of Validity unlimited
Classification Number UP/I-530-09/14-02/422
Registration Number 381-12-01/30-15-07
Prescription Medicinal product subject to medical prescription
Type of prescription Medicinal product subject to special medical prescription
Distribution Supply through pharmacies (community)
Advertising to general public not allowed
ATC Code N02AX06
Marketing status Marketed
Shortage status No shortage
SmPC download
PL download
Public Assessment Report download

Packaging

Back